Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record NCT04505826, replacing the previous content visible to users. This indicates an access restriction or server-side issue that prevents loading the study details.SummaryDifference18%

- Check36 days agoChange DetectedRevision changed from v3.6.5 to v3.6.6, indicating a new release of the page’s content. This update signals administrative or formatting improvements and does not modify the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5, indicating a small platform update rather than a substantive content change.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.6.4 was added and the previous Revision: v3.6.3 was removed, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3. This appears to be a minor maintenance/version-control update rather than a substantive change to the study information or user-facing content.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend release update. No visible changes to study details or page content are evident.SummaryDifference0.0%

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.